Recently, synbio startup BIOFORANY completed an angel round of financing of nearly 50 million yuan. After years of accumulation, BIOFORANY has a complete synthetic biology technology platform, advanced enzyme engineering platform, and enzyme-based green process development technology. It is one of the main pioneers of China's biocatalysis industry.
At present, the R&D center of BIOFORANY in Shanghai and the pilot test base in Suzhou not only have advanced industrial enzyme gene mining and transformation platforms but also have product development platforms for various downstream applications designed by different types of enzymes functional element platforms. BIOFORANY is using high-performance biological components to synthesize a variety of product categories.
Biological enzyme synthesis utilizes natural raw materials, with less energy consumption and less environmental pollution. In the synthesis process, the material is saved and the production cost is reduced. Besides, the drug produced by enzymatic synthesis catalyst has high purity, fewer impurities, and better relative efficacy. However, natural enzyme molecules may be unstable or have low activity, resulting in the high cost for the downstream industrial applications. Therefore, solving the difficulties and pain points of enzymes in industrial application is the key to industrialization, and it requires the accumulation of a lot of engineering practical experience.
Based on many years of practical experience in developing high activity and high selectivity enzyme catalytic elements, and through scientific planning and statistical analysis of natural and artificial enzyme elements, BIOFORANY has constructed a series of industrial leading enzyme entity libraries with more than 3,000 enzymes. All of them have complete intellectual property rights, are broad-spectrum universal, and are highly representative.